PSI PHARMACEUTICALS LTD
Company number 13775713 · Monitor this company
Executive summary
PSI PHARMACEUTICALS LTD presents a low-risk profile with strong liquidity and solvency evidenced by growing net assets and absence of current liabilities. Compliance with filing obligations is current, supporting regulatory stability. However, the absence of employees and reliance on micro-entity accounting exemptions warrant further review to fully understand operational and financial robustness.
Shareholders' funds
£604,728
Balance sheet as at 2025-12-31
What it does
Psi Pharmaceuticals is a Group Holding Company/Parent company of Neurone Ltd and PsiClone Ltd, both of which are involved in Research and Development of Pharmaceutical products.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-12-01
- Employees
- 0 (2025 accounts)
- Registered office
- Chilvester Lodge, Chilvester Hill, Calne, England, SN11 0LP
- Postcode
- SN11 0LP
- Capital
- 55 GBP
- Accounts category
- Micro
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-11-30
- Next due by
- 2026-12-14
Nature of business (SIC)
- 21200 Manufacture of pharmaceutical preparations
- 72110 Research and experimental development on biotechnology
Officers 3 current · 2 resigned
Group structure 2 subsidiaries
From persons-with-significant-control filings on the public register.